PATENT CLAIM ANALYSIS

Application Number: 16042031
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "718000"]

Abstract:
The present invention provides methods of administering nitric oxide (NO) to a patient, the method comprising delivering nitric oxide-containing gas directly into arterial or arterialized blood. The methods of the present invention may be used in the treatment or prevention of a variety of diseases and disorders responsive to nitric oxide, including those resulting from ischemia or hypoxia.

Claim (Index 15):
The ECMO system of  claim 14  further comprising an oxygen venting device in fluid communication with the oxygen transfer unit through an outlet of the oxygen transfer unit operable to receive any remaining oxygen and an NO venting device in fluid communication with the NO transfer unit through the outlet of the NO transfer unit operable to receive any remaining NO.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.3913
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14402786', '14095621', '10953747', '10384301', '13116219']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.693574669863579
- 35 USC 102 Novelty (BERT): 0.5666178247897214
- Combined Prediction Score: 0.6808789853561932
- Mean Citation Score: 283.736874
- Max Citation Score: 462.03397
- Similarity Product: 336.2881570885575

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test